Phase I Validation Study Opens: MEVA Cognitive Wellness Platform for Healthy Aging — Digital Assessment Tool Seeks Reliability Data

References

1. 1.Jak, A. J., Bondi, M. W., Delano-Wood, L., Wierenga, C., Corey-Bloom, J., Salmon, D. P., & Delis, D. C. (2009). Quantification of five neuropsychological approaches to defining mild cognitive impairment. The American Journal of Geriatric Psychiatry, 17(5), 368-375. https://doi.org/10.1097/JGP.0b013e31819431d5
2. 2.Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., ... & Mukadam, N. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396(10248), 413-446. https://doi.org/10.1016/S0140-6736(20)30367-6
3. 3.Mentage LLC. (2024). Phase 1 validation study of the MEVA cognitive wellness platform. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07595250
4. 4.Salthouse, T. A. (2019). Trajectories of normal cognitive aging. Psychology and Aging, 34(1), 17-24. https://doi.org/10.1037/pag0000288
5. 5.Zygouris, S., & Tsolaki, M. (2015). Computerized cognitive testing for older adults: A review. American Journal of Alzheimer's Disease & Other Dementias, 30(1), 13-28. https://doi.org/10.1177/1533317514522852